Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products
about
Interaction between advanced glycation end products formation and vascular responses in femoral and coronary arteries from exercised diabetic ratsTelomeres and Telomerase in Cardiovascular DiseasesAlbumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cellsBeneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanismsArterial stiffness: a brief review.Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease.Insulin resistance, metabolic stress, and atherosclerosis.Uremic Toxicity of Advanced Glycation End Products in CKD.Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications.Longitudinal analysis of short-term high-fat diet on endothelial senescence in baboons.Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis.Macrovascular angiopathy in children and adolescents with type 1 diabetes.RAGE biology, atherosclerosis and diabetes.Does uremia cause vascular dysfunction?Endothelial dysfunction in metabolic and vascular disorders.Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies.Similarities and interactions between the ageing process and high chronic intake of added sugars.Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension?Use of a polysulfone hemodialysis membrane may prevent recurrent posterior reversible encephalopathy syndrome in a patient undergoing hemodialysis.Increased adrenergic contractility and decreased mRNA expression of NOS III in aging rat urinary bladders.Administration of Ginseng radix decreases nitric oxide synthase expression in the hippocampus of streptozotocin-induced diabetic rats.The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis.Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells.Sevelamer reduces endothelial inflammatory response to advanced glycation end products.Low ethanol intake prevents salt-induced hypertension in WKY rats.Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion.
P2860
Q27322359-7DE7FA7A-312A-45C6-ADE9-D48CD15EC0BDQ28076220-45EE5741-C0A7-4431-8065-4DE635C58BD8Q28362386-183893E1-3237-40B0-AADA-CAC63628E660Q30360076-4A8E26AC-0BD6-43C4-ABD0-9CC19AE70F62Q34807187-496284C8-D2F6-45CB-9025-5697E2348473Q35796793-F0C9CA08-DF0A-4F6F-B262-1998CA339695Q35871387-BBDFA9FD-76A5-48FA-BA4B-2082643F33E3Q36514906-AA9A6103-001D-4E47-88C3-916FAFE95051Q36574142-0F75E765-B4AA-4F79-9F35-FF5DC8E5CA7DQ36943327-866714B7-FA22-46BF-A7AC-F8DB8802E410Q37116317-EA0C9343-A9B2-4FFC-8D27-FDA6BD5DAEE4Q37433970-CF5BDE54-23BC-4D50-9E70-45944C64AB89Q37661169-263D22D9-DE50-42F7-87A0-AD2F8E33BACEQ37857087-99A19BE0-6342-48C1-8753-95F978C681BDQ37860348-39348168-5EF0-4643-92B4-13B3B995FD5AQ37892318-DF4AF092-1F8F-44C6-AA19-1E1E3238C076Q38200828-009E7624-3D56-4987-B28B-DFAE27B868DDQ38460480-AA3D9D77-9335-4BBB-9BD1-285B201E3F71Q38782180-EC878679-51AA-4733-BB46-696392E772DEQ39158946-7D9C0912-6279-4E76-9D54-B95D41F6058FQ43706054-AE0CFD39-2F4A-464E-B4A9-67556E667C12Q44711941-36F8891E-9559-454C-ACB3-931BF3AD10B4Q45104623-EDCECA05-872F-4949-8FBA-7015553FAF49Q46425734-F2C0FDD0-52F9-4F16-ACF3-A45BB4A03C97Q46691934-FE05299C-C220-4A7A-B29C-ED0E44A734A5Q48505037-3597F14F-E62F-41DA-8535-FD4970EE4305Q53623623-6C5E351D-B320-468E-8124-EBBDE2F1405DQ54447399-E3B4A0A2-3371-46D0-8F21-DBF34E83FE71
P2860
Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Regulation of endothelial nitr ...... ced glycosylation end products
@ast
Regulation of endothelial nitr ...... ced glycosylation end products
@en
Regulation of endothelial nitr ...... ced glycosylation end products
@nl
type
label
Regulation of endothelial nitr ...... ced glycosylation end products
@ast
Regulation of endothelial nitr ...... ced glycosylation end products
@en
Regulation of endothelial nitr ...... ced glycosylation end products
@nl
prefLabel
Regulation of endothelial nitr ...... ced glycosylation end products
@ast
Regulation of endothelial nitr ...... ced glycosylation end products
@en
Regulation of endothelial nitr ...... ced glycosylation end products
@nl
P2093
P3181
P356
P1433
P1476
Regulation of endothelial nitr ...... ced glycosylation end products
@en
P2093
P3181
P356
10.1161/01.RES.86.3.E50
P407
P577
2000-02-18T00:00:00Z